The trademark application Cellline was filed by Pamex Pharmaceuticals GmbH Lietuvos filialas, a corporation established under the laws of the Republic of Lithuania (the "Applicant"). The application was published for oppositions on September 23, 2025, and still open for oppositions.
The application was filed in Lithuanian (English was selected as the second language).